Systemic review of the epidemiology of autism in Arab Gulf countries

References

1. ↵
   1. Elsabbagh M,
   2. Divan G,
   3. Koh YJ,
   4. Kim YS,
   5. Kauchali S,
   6. Marcin C,
   7. et al.

   (2012) Global prevalence of autism and other pervasive developmental disorders. Autism Res 5, 160–179.
2. ↵
   1. Rapin I

   (1997) Autism. N Engl J Med 337, 97–104, Review.
3. ↵
   1. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)

   (2000) (American Psychiatric Association, Washington (DC)), 4th ed.
4. ↵
   1. Lotter V

   (1966) Epidemiology of autistic conditions in young children: I. Prevalence. Social Psychiatry 1, 124–137.
5. ↵
   1. Burd L,
   2. Fisher W,
   3. Kerbeshian J

   (1987) A prevalence study of pervasive developmental disorders in North Dakota. J Am Acad Child Adolesc Psychiatry 26, 700–703.
6. ↵
   1. Manning-Courtney P,
   2. Murray D,
   3. Currans K,
   4. Johnson H,
   5. Bing N,
   6. Kroeger-Geoppinger K,
   7. et al.

   (2013) Autism spectrum disorders. Curr Probl Pediatr Adolesc Health Care 43, 2–11.
7. ↵
   1. Ganz ML

   (2007) The lifetime distribution of the incremental societal costs of autism. Arch Pediatr Adolesc Med 161, 343–349.
8. ↵
   1. Knapp M,
   2. Romeo R,
   3. Beecham J

   (2009) Economic cost of autism in the UK. Autism 13, 317–336.
9. ↵
   1. Daley TC

   (2004) From symptom recognition to diagnosis: children with autism in urban India. Soc Sci Med 58, 1323–1335.
10. 1. Juneja M,
    2. Mukherjee SB,
    3. Sharma S

    (2005) A descriptive hospital based study of children with autism. Indian Pediatr 42, 453–458.
11. ↵
    1. Singhi P,
    2. Malhi P

    (2001) Clinical and neurodevelopmental profile of young children with autism. Indian Pediatr 38, 384–390.
12. ↵
    1. Newschaffer CJ,
    2. Fallin D,
    3. Lee NL

    (2002) Heritable and nonheritable risk factors for autism spectrum disorders. Epidemiologic Rev 24, 137–153.
13. ↵
    1. Corsello CM

    (2005) Early Intervention in Autism. Infants & Young Children 18, 74–85.
14. 1. Smith T,
    2. Groen AD,
    3. Wynn JW

    (2000) Randomized trial of intensive early intervention for children with pervasive developmental disorder. Am J Ment Retard 105, 269–285.
15. ↵
    1. McConachie H,
    2. Diggle T

    (2007) Parent implemented early intervention for young children with autism spectrum disorder: a systematic review. J Eval Clin Pract 13, 120–129.
16. ↵
    1. Al-Ansari AM,
    2. Ahmed MM

    (2012) Parental age. Risk of autistic disorder. Neurosciences 17, 382–383.
17. ↵
    1. Al-Ansari AM,
    2. Ahmed MM

    (2013) Epidemiology of autistic disorder in Bahrain: prevalence and obstetric and familial characteristics. Mediterr Health J 19, 769–774.
18. ↵
    1. Eapen V,
    2. Mabrouk AA,
    3. Zoubeidi T,
    4. Yunis F

    (2007) Prevalence of pervasive developmental disorders in preschool children in the UAE. J Trop Pediatr 53, 202–205.
19. ↵
    1. Al-Salehi SM,
    2. Al-Hifthy EH,
    3. Ghaziuddin M

    (2009) Autism in Saudi Arabia: presentation, clinical correlates and comorbidity. Transcult Psychiatry 46, 340–347.
20. ↵
    1. Al-Farsi YM,
    2. Al-Sharbati MM,
    3. Al-Farsi OA,
    4. Al-Shafaee MS,
    5. Brooks DR,
    6. Waly MI

    (2011) Brief report: Prevalence of autistic spectrum disorders in the Sultanate of Oman. J Autism Dev Disord 41, 821–825.
21. ↵
    1. Al-Farsi YM,
    2. Al-Sharbati MM,
    3. Waly MI,
    4. Al-Farsi OA,
    5. Al-Shafaee MA,
    6. Al-Khaduri MM,
    7. et al.

    (2012) Effect of suboptimal breast-feeding on occurrence of autism: a case-control study. Nutrition 28, e27–e32.
22. ↵
    1. El-Ansary AK,
    2. Bacha AB,
    3. Ayahdi LY

    (2011) Relationship between chronic lead toxicity and plasma neurotransmitters in autistic patients from Saudi Arabia. Clin Biochem 44, 1116–1120.
23. ↵
    1. Al-ayadhi LY,
    2. Mostafa GA

    (2011) Increased serum osteopontin levels in autistic children: relation to the disease severity. Brain, Behav Immun 25, 1393–1398.
24. ↵
    1. Al-Gadani Y,
    2. El-Ansary A,
    3. Attas O,
    4. Al-Ayadhi L

    (2009) Metabolic biomarkers related to oxidative stress and antioxidant status in Saudi autistic children. Clin Biochem 42, 1032–1040.
25. ↵
    1. Al-Mosalem OA,
    2. El-Ansary A,
    3. Attas O,
    4. Al-Ayadhi L

    (2009) Metabolic biomarkers related to energy metabolism in Saudi autistic children. Clin Biochem 42, 949–957.
26. ↵
    1. El-Ansary AK,
    2. Bacha AG,
    3. Al-Ayahdi LY

    (2011) Plasma fatty acids as diagnostic markers in autistic patients from Saudi Arabia. Lipids Health Dis 10, 62.
27. ↵
    1. Ali A,
    2. Waly MI,
    3. Al-Farsi YM,
    4. Essa MM,
    5. Al-Sharbati MM,
    6. Deth RC

    (2011) Hyperhomocysteinemia among Omani autistic children: a case-control study. Acta Biochim Pol 58, 547–551.
28. ↵
    1. Amr M

    (2011) Addressing autism in the Arab world. Nature Middle East 147, 1–2.
29. ↵
    1. Waly M,
    2. Olteanu H,
    3. Banerjee R,
    4. Choi SW,
    5. Mason JB,
    6. Parker BS,
    7. et al.

    (2004) Activation of methionine synthase by insulin-like growth factor-1 and dopamine: a target for neurodevelopmental toxins and thimerosal. Molecular Psychiatry 9, 358–370.
30. ↵
    1. Schultz ST,
    2. Klonoff-Cohen HS,
    3. Wingard DL,
    4. Akshoomoff NA,
    5. Macera CA,
    6. Ji M,
    7. et al.

    (2006) Breastfeeding, infant formula supplementation, and Autistic Disorder: the results of a parent survey. Int Breastfeed J 1, 16.
31. ↵
    1. Gallup GG Jr.,
    2. Hobbs DR

    (2011) Evolutionary medicine: bottle feeding, birth spacing, and autism. Med Hypotheses 77, 345–346.
32. ↵
    1. Sgaravatti AM,
    2. Rosa RB,
    3. Schuck PF,
    4. Ribeiro CA,
    5. Wannmacher CM,
    6. Wyse AT,
    7. et al.

    (2003) Inhibition of brain energy metabolism by the alpha-keto acids accumulating in maple syrup urine disease. Biochimica Biophysica Acta 1639, 232–238.
33. 1. Yorbik O,
    2. Sayal A,
    3. Akay C,
    4. Akbiyik DI,
    5. Sohmen T

    (2002) Investigation of antioxidant enzymes in children with autistic disorder. Prostaglandins Leukot Essent Fatty Acids 67, 341–343.
34. 1. Herndon AC,
    2. DiGuiseppi C,
    3. Johnson SL,
    4. Leiferman J,
    5. Reynolds A

    (2009) Does nutritional intake differ between children with autism spectrum disorders and children with typical development? J Autism Dev Disord 39, 212–222.
35. ↵
    1. Zoroglu SS,
    2. Armutcu F,
    3. Ozen S,
    4. Gurel A,
    5. Sivasli E,
    6. Yetkin O,
    7. et al.

    (2004) Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism. Eur Arch Psychiatry Clin Neurosci 254, 143–147.